These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15939051)

  • 1. The PPARdelta agonist GW0742X reduces atherosclerosis in LDLR(-/-) mice.
    Graham TL; Mookherjee C; Suckling KE; Palmer CN; Patel L
    Atherosclerosis; 2005 Jul; 181(1):29-37. PubMed ID: 15939051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor δ agonist GW1516 attenuates diet-induced aortic inflammation, insulin resistance, and atherosclerosis in low-density lipoprotein receptor knockout mice.
    Bojic LA; Burke AC; Chhoker SS; Telford DE; Sutherland BG; Edwards JY; Sawyez CG; Tirona RG; Yin H; Pickering JG; Huff MW
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):52-60. PubMed ID: 24158519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A selective peroxisome proliferator-activated receptor δ agonist PYPEP suppresses atherosclerosis in association with improvement of the serum lipoprotein profiles in human apolipoprotein B100 and cholesteryl ester transfer protein double transgenic mice.
    Naya N; Fukao K; Nakamura A; Hamada T; Sugimoto M; Kojima M; Yoshimura N; Uwabe K; Imagawa K; Nomura K; Hara S; Nakano T; Iwasaki T; Shinosaki T; Hanasaki K
    Metabolism; 2016 Jan; 65(1):16-25. PubMed ID: 26683793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPARdelta-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis.
    Takata Y; Liu J; Yin F; Collins AR; Lyon CJ; Lee CH; Atkins AR; Downes M; Barish GD; Evans RM; Hsueh WA; Tangirala RK
    Proc Natl Acad Sci U S A; 2008 Mar; 105(11):4277-82. PubMed ID: 18337495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
    Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced aortic macrophage lipid accumulation and inflammatory response in LDL receptor null mice fed an atherogenic diet.
    Wang S; Wu D; Matthan NR; Lamon-Fava S; Lecker JL; Lichtenstein AH
    Lipids; 2010 Aug; 45(8):701-11. PubMed ID: 20686867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both the peroxisome proliferator-activated receptor delta agonist, GW0742, and ezetimibe promote reverse cholesterol transport in mice by reducing intestinal reabsorption of HDL-derived cholesterol.
    Briand F; Naik SU; Fuki I; Millar JS; Macphee C; Walker M; Billheimer J; Rothblat G; Rader DJ
    Clin Transl Sci; 2009 Apr; 2(2):127-33. PubMed ID: 20169010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel peroxisome proliferator response element modulates hepatic low-density lipoprotein receptor gene transcription in response to PPARδ activation.
    Shende VR; Singh AB; Liu J
    Biochem J; 2015 Dec; 472(3):275-86. PubMed ID: 26443862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic knockdown of PPARδ reduces atherosclerosis in LDLR-/- mice.
    Li G; Chen C; Laing SD; Ballard C; Biju KC; Reddick RL; Clark RA; Li S
    Gene Ther; 2016 Jan; 23(1):78-85. PubMed ID: 26204499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of atherosclerosis in LDL receptor knockout mice: macrophage accumulation correlates with rapid and sustained expression of aortic MCP-1/JE.
    Kowala MC; Recce R; Beyer S; Gu C; Valentine M
    Atherosclerosis; 2000 Apr; 149(2):323-30. PubMed ID: 10729382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma.
    Li AC; Binder CJ; Gutierrez A; Brown KK; Plotkin CR; Pattison JW; Valledor AF; Davis RA; Willson TM; Witztum JL; Palinski W; Glass CK
    J Clin Invest; 2004 Dec; 114(11):1564-76. PubMed ID: 15578089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.
    Ooi EM; Watts GF; Sprecher DL; Chan DC; Barrett PH
    J Clin Endocrinol Metab; 2011 Oct; 96(10):E1568-76. PubMed ID: 21816786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low density lipoprotein receptor of macrophages facilitates atherosclerotic lesion formation in C57Bl/6 mice.
    Herijgers N; Van Eck M; Groot PH; Hoogerbrugge PM; Van Berkel TJ
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1961-7. PubMed ID: 10938018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARdelta agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet.
    Nagasawa T; Inada Y; Nakano S; Tamura T; Takahashi T; Maruyama K; Yamazaki Y; Kuroda J; Shibata N
    Eur J Pharmacol; 2006 Apr; 536(1-2):182-91. PubMed ID: 16574099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
    Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice.
    Nachtigal P; Pospisilova N; Jamborova G; Pospechova K; Solichova D; Andrys C; Zdansky P; Micuda S; Semecky V
    Life Sci; 2008 Mar; 82(13-14):708-17. PubMed ID: 18289605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of coexpression of the LDL receptor and apoE on cholesterol metabolism and atherosclerosis in LDL receptor-deficient mice.
    Kawashiri M; Zhang Y; Usher D; Reilly M; Puré E; Rader DJ
    J Lipid Res; 2001 Jun; 42(6):943-50. PubMed ID: 11369802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor δ: a multifaceted metabolic player.
    Bojic LA; Huff MW
    Curr Opin Lipidol; 2013 Apr; 24(2):171-7. PubMed ID: 23481229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aortic cholesterol accumulation correlates with systemic inflammation but not hepatic and gonadal adipose tissue inflammation in low-density lipoprotein receptor null mice.
    Wang S; Miller B; Matthan NR; Goktas Z; Wu D; Reed DB; Yin X; Grammas P; Moustaid-Moussa N; Shen CL; Lichtenstein AH
    Nutr Res; 2013 Dec; 33(12):1072-82. PubMed ID: 24267047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced cholesterol absorption upon PPARdelta activation coincides with decreased intestinal expression of NPC1L1.
    van der Veen JN; Kruit JK; Havinga R; Baller JF; Chimini G; Lestavel S; Staels B; Groot PH; Groen AK; Kuipers F
    J Lipid Res; 2005 Mar; 46(3):526-34. PubMed ID: 15604518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.